KR950703962A - 중추 신경계 질병을 치료하기 위한 트리아 졸로퀴나졸린(Triazoloquinazolines for the Treatment of Diseases of the Central Nervous System) - Google Patents
중추 신경계 질병을 치료하기 위한 트리아 졸로퀴나졸린(Triazoloquinazolines for the Treatment of Diseases of the Central Nervous System)Info
- Publication number
- KR950703962A KR950703962A KR1019950702355A KR19950702355A KR950703962A KR 950703962 A KR950703962 A KR 950703962A KR 1019950702355 A KR1019950702355 A KR 1019950702355A KR 19950702355 A KR19950702355 A KR 19950702355A KR 950703962 A KR950703962 A KR 950703962A
- Authority
- KR
- South Korea
- Prior art keywords
- alkyl
- treatment
- formula
- compound
- group
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
중추 신경 장해를 조절하기 위한 약물 제조를 위한 트리아졸로퀴나졸린의 용도를 기재하고 있다. 트리아졸로퀴나졸린은 하기 식(Ⅰ)과 같다.
상기 식에서 R1, R2및 X는 설명에 정의된 바와 같다.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (3)
- 식(Ⅰ)의 화합물 및 생리학적으로 용인되는 산부가염의 중추 신경 장해 치료 약물의 제조를 위한 용도.상기식에서, X는 카르복실(이는 생리학적으로 용인되는 아민 양이온 또는 금속 양이온과의 염의 형태로 적합하다).[여기서, R4은 C1-8알킬, 고리에 3내지 8개의 탄소 원자를 갖는 시클로알킬, 벤진, (CH2)n-O-R5또는중의 하나인 기(여기서, n은 2, 3 또는 4이고, R5및 R6은 각각 C1-3-알킬이다)]. 히드록시-C1-4-알킬, 니트릴-C1-4-알킬, 테트라졸일, 카르보닐아미노테트라졸 또는 카르바모일이고, R1은 R2와 같거나 다르며, 수소, 불소, 염소 또는 브롬 원자, 트리플루오로메틸, 니트로, 아미노, C1-5-알킬, 모노 또는 디-C1-5-알킬아미노기, C1-6-알콕시기, C1-6-알킬티오,C1-6-알킬슐페닐, -C1-6알킬술포닐, 디-C1-6-알킬아미노술포닐기, 또는 R1및 R2는 함께 메틸렌-또는 에틸렌디옥시기 또는 C3-5-알킬렌기를 형성한다.
- 제1항에 따른 식(Ⅰ)의 화합물의 내용물을 가지는 중추 신경 장해의 치료를 위한 약물.
- 제1항에 따른 식(Ⅰ)의 화합물을 치료 유효량 투여하는 것으로 이루어지는, 중추신경 장애 환자의 치료방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEP4241564.0 | 1992-12-10 | ||
DE4241564A DE4241564A1 (de) | 1992-12-10 | 1992-12-10 | Triazolochinazoline zur Behandlung zentralnervöser Erkrankungen |
PCT/EP1993/003424 WO1994013294A1 (de) | 1992-12-10 | 1993-12-06 | Triazolochinazoline zur behandlung zentralnervöser erkrankungen |
Publications (1)
Publication Number | Publication Date |
---|---|
KR950703962A true KR950703962A (ko) | 1995-11-17 |
Family
ID=6474850
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019950702355A KR950703962A (ko) | 1992-12-10 | 1993-12-06 | 중추 신경계 질병을 치료하기 위한 트리아 졸로퀴나졸린(Triazoloquinazolines for the Treatment of Diseases of the Central Nervous System) |
Country Status (13)
Country | Link |
---|---|
US (1) | US5612344A (ko) |
EP (1) | EP0673249B1 (ko) |
JP (1) | JPH08504418A (ko) |
KR (1) | KR950703962A (ko) |
AT (1) | ATE177637T1 (ko) |
AU (1) | AU673225B2 (ko) |
CA (1) | CA2151241A1 (ko) |
CZ (1) | CZ144895A3 (ko) |
DE (2) | DE4241564A1 (ko) |
MX (1) | MX9307837A (ko) |
NZ (1) | NZ258887A (ko) |
WO (1) | WO1994013294A1 (ko) |
ZA (1) | ZA939229B (ko) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH490362A (de) * | 1967-04-03 | 1970-05-15 | Upjohn Co | Verfahren zur Herstellung von 20-Ketosteroidverbindungen |
DE3146599A1 (de) * | 1981-11-25 | 1983-07-07 | Basf Ag, 6700 Ludwigshafen | Neue triazolochinazoline, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen |
US4713383A (en) * | 1984-10-01 | 1987-12-15 | Ciba-Geigy Corporation | Triazoloquinazoline compounds, and their methods of preparation, pharmaceutical compositions, and uses |
EP0181282A1 (de) * | 1984-10-01 | 1986-05-14 | Ciba-Geigy Ag | Triazolochinazolinverbindungen |
US5153196A (en) * | 1991-06-05 | 1992-10-06 | Eli Lilly And Company | Excitatory amino acid receptor antagonists and methods for the use thereof |
-
1992
- 1992-12-10 DE DE4241564A patent/DE4241564A1/de not_active Withdrawn
-
1993
- 1993-12-06 NZ NZ258887A patent/NZ258887A/en unknown
- 1993-12-06 CA CA002151241A patent/CA2151241A1/en not_active Abandoned
- 1993-12-06 WO PCT/EP1993/003424 patent/WO1994013294A1/de active IP Right Grant
- 1993-12-06 US US08/433,509 patent/US5612344A/en not_active Expired - Fee Related
- 1993-12-06 DE DE59309469T patent/DE59309469D1/de not_active Expired - Fee Related
- 1993-12-06 KR KR1019950702355A patent/KR950703962A/ko not_active Application Discontinuation
- 1993-12-06 EP EP94902687A patent/EP0673249B1/de not_active Expired - Lifetime
- 1993-12-06 CZ CZ951448A patent/CZ144895A3/cs unknown
- 1993-12-06 AT AT94902687T patent/ATE177637T1/de not_active IP Right Cessation
- 1993-12-06 AU AU56965/94A patent/AU673225B2/en not_active Ceased
- 1993-12-06 JP JP6513758A patent/JPH08504418A/ja active Pending
- 1993-12-09 ZA ZA939229A patent/ZA939229B/xx unknown
- 1993-12-10 MX MX9307837A patent/MX9307837A/es unknown
Also Published As
Publication number | Publication date |
---|---|
CZ144895A3 (en) | 1995-12-13 |
MX9307837A (es) | 1994-07-29 |
JPH08504418A (ja) | 1996-05-14 |
ZA939229B (en) | 1995-06-09 |
EP0673249A1 (de) | 1995-09-27 |
ATE177637T1 (de) | 1999-04-15 |
AU5696594A (en) | 1994-07-04 |
CA2151241A1 (en) | 1994-06-23 |
DE4241564A1 (de) | 1994-06-16 |
AU673225B2 (en) | 1996-10-31 |
WO1994013294A1 (de) | 1994-06-23 |
DE59309469D1 (de) | 1999-04-22 |
US5612344A (en) | 1997-03-18 |
EP0673249B1 (de) | 1999-03-17 |
NZ258887A (en) | 1997-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ITMI922006A1 (it) | Esteri nitrici di derivati dell'acido 2-(2, 6-di-alo-fenilammino) fenilacetico e procedimento per la loro preparazione | |
RU98108027A (ru) | Производные имидазола, обладающие аффинностью в отношении активности альфа2- рецепторов | |
OA09482A (fr) | "Nouveaux dérivés à structure naphtalénique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent". | |
BR9510452A (pt) | Composição farmacêutica e aquosa estéril para a administração parenteral processos para limitar o potencial de crescimento microbiano em composição farmacêutica estéril para a administração parenteral para produzir anestesia em um animal de sangue quente e para aperfeiçoar o tempo de administração e/ou o tempo entre as trocas de conjuntos | |
MX9710261A (es) | Compuestos aromaticos y composiciones farmaceuticas que los contienen. | |
KR950704283A (ko) | 신경제제로서 유용한 1,4-벤조티아제핀(1,4-Benzothiazepines useful as neurological agents) | |
IS4218A (is) | Hliðstæð aðferð við að framleiða skammvirk tvíhýdrópýridín | |
RU99127433A (ru) | Эрголиновые производные и их применение в качестве антагонистов рецепторов соматостатина | |
SE9601677D0 (sv) | New use | |
BR9507231A (pt) | Uso de derivados de ácido carboxílico para a produção de drogas | |
KR880013886A (ko) | 신규 알칸술폰아닐리드 유도체, 그의 제조방법 및 이를 함유하는 제약 조성물 | |
ATE150745T1 (de) | 22-en-25-oxa-derivate in der vitamin d-reihe, verfahren zu ihrer herstellung, diese derivate enthaltenen pharmazeutische präparate sowie deren verwendung als arzneimittel | |
FI964482A (fi) | Amidijohdannaisia ja niiden käyttö lääkkeenä | |
LV11323A (lv) | Izohinolina atvasinajumi ka arstnieciskie lidzekli | |
KR950703962A (ko) | 중추 신경계 질병을 치료하기 위한 트리아 졸로퀴나졸린(Triazoloquinazolines for the Treatment of Diseases of the Central Nervous System) | |
RU94046144A (ru) | Замещенные (арилалкиламинобензил) аминопропионамидные производные, их применение, способы их получения, фармкомпозиция | |
KR950018047A (ko) | 18 환 원자를 갖는 신규한 사이클릭 뎁시펩타이드 및 내부 기생충을 구제하는 이의 용도 | |
KR890006621A (ko) | 항불안제 | |
KR880007498A (ko) | 중추작용 근이완제 | |
RU2002132883A (ru) | Новые полициклические инданилимидазолы, обладающие альфа2 адренергической активностью | |
KR930703013A (ko) | 항당뇨병제로서 유용한 신규한 글루코하이드롤라제 억제제 | |
KR960705791A (ko) | 기억력 향상제로서 유용한 3-아릴-4-알킬 및 4,5-디알킬-4H-1,2,4-트리아졸(3Aryl-4-alkyl and 4,5-dialkyl-4H-1,2,4-triazoles useful as memory enhancers) | |
ES2109512T3 (es) | Macrolactama (ciclamenol) antiinflamatoria. | |
KR930019640A (ko) | 테트라히드로피리미딘 유도체 | |
DE59309898D1 (de) | 4-oxo-azetidin-2-sulfonsäureamide und ihre salze, verfahren zu deren herstellung und ihre verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |